Two-Dimensional Nanomaterials for Cancer Nanotheranostics

Small. 2017 Mar;13(10). doi: 10.1002/smll.201603446. Epub 2017 Jan 11.

Abstract

Emerging nanotechnologies show unprecedented advantages in accelerating cancer theranostics. Among them, two-dimensional nanomaterials (2DNMs) represent a novel type of material with versatile physicochemical properties that have enabled a new horizon for applications in both cancer diagnosis and therapy. Studies have demonstrated that 2DNMs may be used in diverse aspects, including i) cancer detection due to their high propensity towards tumor markers; ii) molecular imaging for guided tumor therapies, and iii) drug and gene loading, photothermal and photodynamic cancer therapies. However, their biomedical applications raise concerns due to the limited understanding of their in vivo metabolism, transformation and possible toxicities. In this comprehensive review, the state-of-the-art development of 2DNMs and their implications for cancer nanotheranostics are presented. The modification strategies to enhance the biocompatibility of 2DNMs are also reviewed.

Keywords: bioimaging; cancer; drug delivery; nanotheranostics; two-dimensional nanomaterials.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Nanostructures / chemistry*
  • Nanotechnology / methods*
  • Neoplasms / drug therapy*
  • Neoplasms / therapy*
  • Photochemotherapy / methods
  • Theranostic Nanomedicine / methods*